B.Riley Starts Verastem (VSTM) at Buy, "Verastem’s combo regimen is poised for strong market penetration"
Tweet Send to a Friend
(Updated - September 26, 2023 8:02 PM EDT)
B.Riley analyst Kalpit Patel initiates coverage on Verastem (NASDAQ: VSTM) with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
B.Riley analyst Kalpit Patel initiates coverage on Verastem (NASDAQ: VSTM) with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
